TrueHLTH, a pioneering patient advocacy and healthcare navigation company, has announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO).
The patent application revolves around TrueHLTH‘s platform, specifically designed to assist individuals with chronic conditions and their caregivers. The always-on platform operates 24/7, 365 days a year, and aims to identify and address personal challenges that may hinder patients from proactively seeking necessary care interventions.
TrueHLTH was established to bridge the existing gap in navigating the complex healthcare system for those with chronic diseases. Scott Genone, the co-founder and CEO of TrueHLTH, brings his extensive experience as a healthcare technology leader spanning three decades and personal encounters with the intricacies of care delivery in the United States, including his family’s journey in managing his oldest son’s health and his own challenges with Crohn’s Disease.
“Our focus is to build patient trust through unparalleled advocacy. Trust fosters patient activation and engagement with our platform, while active engagement enables continuous data capture. This data powers our AI system, allowing it to evolve and anticipate challenges, enabling proactive interventions to help patients maintain wellness,” explains Mr. Genone.
TrueHLTH operates on a mission-driven approach, addressing the challenges from the perspective of patients and their caregivers.
For more information, please visit:
The post TrueHLTH Files Provisional Patent for Predictive AI Systems to Improve Chronic Disease Management first appeared on BusinessMole.